Altavista Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,714
Closed -$215K 190
2021
Q3
$215K Sell
1,714
-41
-2% -$5.31K 0.05% 179
2021
Q2
$218K Hold
1,755
0.05% 177
2021
Q1
$207K Sell
1,755
-50
-3% -$5.86K 0.05% 170
2020
Q4
$211K Buy
+1,805
New +$199K 0.05% 168
2018
Q4
Sell
-2,148
Closed -$211K 152
2018
Q3
$211K Buy
+2,148
New +$199K 0.08% 147
2018
Q2
Sell
-5,113
Closed -$410K 148
2018
Q1
$410K Buy
5,113
+46
+0.9% +$3.79K 0.17% 99
2017
Q4
$409K Buy
5,067
+2,178
+75% +$174K 0.17% 103
2017
Q3
$225K Sell
2,889
-58
-2% -$4.82K 0.11% 130
2017
Q2
$262K Buy
2,947
+420
+17% +$35.4K 0.13% 116
2017
Q1
$204K Sell
2,527
-860
-25% -$67.2K 0.1% 125
2016
Q4
$241K Sell
3,387
-532
-14% -$41.8K 0.13% 115
2016
Q3
$339K Buy
+3,919
New +$341K 0.18% 97

Other funds holding MDT

Altavista Wealth Management's MDT Position: Q4 2021 in Review

Altavista Wealth Management sold out of Medtronic (MDT) in Q4 2021, closing a stake of 1,714 shares — an estimated $215K sold.

Altavista Wealth Management first reported a position in MDT in Q3 2016 and held it in 12 quarters. The position peaked at $410K in Q1 2018. 2,060 funds tracked by Wall St. Rank hold MDT as of Q4 2021.

  • Altavista Wealth Management reported no remaining Medtronic position as of Q4 2021 after selling out during the quarter.
  • Altavista Wealth Management sold 1,714 Medtronic shares in Q4 2021, an estimated $215K.
  • Altavista Wealth Management first reported a position in Medtronic in Q3 2016 and held it in 12 quarters.
  • Altavista Wealth Management's Medtronic position peaked at $410K in Q1 2018.
  • 2,060 funds tracked by Wall St. Rank held Medtronic as of Q4 2021.

Based on Altavista Wealth Management's 13F filing for Q4 2021, filed 14 Feb 2022.